Literature DB >> 11157069

Presenilin-1 mutations reduce cytoskeletal association, deregulate neurite growth, and potentiate neuronal dystrophy and tau phosphorylation.

G Pigino1, A Pelsman, H Mori, J Busciglio.   

Abstract

Mutations in presenilin genes are linked to early onset familial Alzheimer's disease (FAD). Previous work in non-neuronal cells indicates that presenilin-1 (PS1) associates with cytoskeletal elements and that it facilitates Notch1 signaling. Because Notch1 participates in the control of neurite growth, cultured hippocampal neurons were used to investigate the cytoskeletal association of PS1 and its potential role during neuronal development. We found that PS1 associates with microtubules (MT) and microfilaments (MF) and that its cytoskeletal association increases dramatically during neuronal development. PS1 was detected associated with MT in the central region of neuronal growth cones and with MF in MF-rich areas extending into filopodia and lamellipodia. In differentiated neurons, PS1 mutations reduced the interaction of PS1 with cytoskeletal elements, diminished the nuclear translocation of the Notch1 intracellular domain (NICD), and promoted a marked increase in total neurite length. In developing neurons, PS1 overexpression increased the nuclear translocation of NICD and inhibited neurite growth, whereas PS1 mutations M146V, I143T, and deletion of exon 9 (D9) did not facilitate NICD nuclear translocation and had no effect on neurite growth. In cultures that were treated with amyloid beta (Abeta), PS1 mutations significantly increased neuritic dystrophy and AD-like changes in tau such as hyperphosphorylation, release from MT, and increased tau protein levels. We conclude that PS1 participates in the regulation of neurite growth and stabilization in both developing and differentiated neurons. In the Alzheimer's brain PS1 mutations may promote neuritic dystrophy and tangle formation by interfering with Notch1 signaling and enhancing pathological changes in tau.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11157069      PMCID: PMC6762317     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  68 in total

1.  Proteolytic fragments of Alzheimer's disease-associated presenilin 1 are present in synaptic organelles and growth cone membranes of rat brain.

Authors:  D Beher; C Elle; J Underwood; J B Davis; R Ward; E Karran; C L Masters; K Beyreuther; G Multhaup
Journal:  J Neurochem       Date:  1999-04       Impact factor: 5.372

2.  Cell surface expression of the Alzheimer disease-related presenilin proteins.

Authors:  N N Dewji; S J Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

3.  Regulation of dendritic growth and remodeling by Rho, Rac, and Cdc42.

Authors:  R Threadgill; K Bobb; A Ghosh
Journal:  Neuron       Date:  1997-09       Impact factor: 17.173

4.  Endogenous presenilin 1 redistributes to the surface of lamellipodia upon adhesion of Jurkat cells to a collagen matrix.

Authors:  A L Schwarzman; N Singh; M Tsiper; L Gregori; A Dranovsky; M P Vitek; C G Glabe; P H St George-Hyslop; D Goldgaber
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

5.  Cellular expression and proteolytic processing of presenilin proteins is developmentally regulated during neuronal differentiation.

Authors:  A Capell; R Saffrich; J C Olivo; L Meyn; J Walter; J Grünberg; P Mathews; R Nixon; C Dotti; C Haass
Journal:  J Neurochem       Date:  1997-12       Impact factor: 5.372

6.  The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex.

Authors:  A Capell; J Grünberg; B Pesold; A Diehlmann; M Citron; R Nixon; K Beyreuther; D J Selkoe; C Haass
Journal:  J Biol Chem       Date:  1998-02-06       Impact factor: 5.157

7.  Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo.

Authors:  D R Borchelt; G Thinakaran; C B Eckman; M K Lee; F Davenport; T Ratovitsky; C M Prada; G Kim; S Seekins; D Yager; H H Slunt; R Wang; M Seeger; A I Levey; S E Gandy; N G Copeland; N A Jenkins; D L Price; S G Younkin; S S Sisodia
Journal:  Neuron       Date:  1996-11       Impact factor: 17.173

8.  Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease.

Authors:  A C Alonso; T Zaidi; I Grundke-Iqbal; K Iqbal
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

9.  beta-Amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology.

Authors:  C J Pike; B J Cummings; C W Cotman
Journal:  Neuroreport       Date:  1992-09       Impact factor: 1.837

10.  Distribution and possible interactions of actin-associated proteins and cell adhesion molecules of nerve growth cones.

Authors:  P C Letourneau; T A Shattuck
Journal:  Development       Date:  1989-03       Impact factor: 6.868

View more
  34 in total

1.  Autophagy in neurite injury and neurodegeneration: in vitro and in vivo models.

Authors:  Charleen T Chu; Edward D Plowey; Ruben K Dagda; Robert W Hickey; Salvatore J Cherra; Robert S B Clark
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

2.  Presenilin-based genetic screens in Drosophila melanogaster identify novel notch pathway modifiers.

Authors:  Matt B Mahoney; Annette L Parks; David A Ruddy; Stanley Y K Tiong; Hanife Esengil; Alexander C Phan; Panos Philandrinos; Christopher G Winter; Runa Chatterjee; Kari Huppert; William W Fisher; Lynn L'Archeveque; Felipa A Mapa; Wendy Woo; Michael C Ellis; Daniel Curtis
Journal:  Genetics       Date:  2006-01-16       Impact factor: 4.562

Review 3.  Axonal transport defects in neurodegenerative diseases.

Authors:  Gerardo A Morfini; Matthew Burns; Lester I Binder; Nicholas M Kanaan; Nichole LaPointe; Daryl A Bosco; Robert H Brown; Hannah Brown; Ashutosh Tiwari; Lawrence Hayward; Julia Edgar; Klaus-Armin Nave; James Garberrn; Yuka Atagi; Yuyu Song; Gustavo Pigino; Scott T Brady
Journal:  J Neurosci       Date:  2009-10-14       Impact factor: 6.167

4.  MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons.

Authors:  Woori Kim; Haneul Noh; Yenarae Lee; Jeha Jeon; Arthi Shanmugavadivu; Donna L McPhie; Kwang-Soo Kim; Bruce M Cohen; Hyemyung Seo; Kai C Sonntag
Journal:  Mol Neurobiol       Date:  2014-11-19       Impact factor: 5.590

5.  Alzheimer amyloid beta inhibition of Eg5/kinesin 5 reduces neurotrophin and/or transmitter receptor function.

Authors:  Csilla Ari; Sergiy I Borysov; Jiashin Wu; Jaya Padmanabhan; Huntington Potter
Journal:  Neurobiol Aging       Date:  2014-02-10       Impact factor: 4.673

6.  Presenilin PS1∆E9 disrupts mobility of secretory organelles in rat astrocytes.

Authors:  M Stenovec; S Trkov Bobnar; T Smolič; M Kreft; V Parpura; R Zorec
Journal:  Acta Physiol (Oxf)       Date:  2018-02-19       Impact factor: 6.311

7.  Aberrant activation of focal adhesion proteins mediates fibrillar amyloid beta-induced neuronal dystrophy.

Authors:  Elizabeth A Grace; Jorge Busciglio
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

8.  PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations.

Authors:  Lia Baki; Junichi Shioi; Paul Wen; Zhiping Shao; Alexander Schwarzman; Miguel Gama-Sosa; Rachael Neve; Nikolaos K Robakis
Journal:  EMBO J       Date:  2004-06-10       Impact factor: 11.598

9.  Hyperhomocysteinemia increases beta-amyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain.

Authors:  Chang-E Zhang; Wei Wei; Ying-Hua Liu; Jun-Hua Peng; Qing Tian; Gong-Ping Liu; Yao Zhang; Jian-Zhi Wang
Journal:  Am J Pathol       Date:  2009-03-05       Impact factor: 4.307

10.  Alzheimer Abeta peptide induces chromosome mis-segregation and aneuploidy, including trisomy 21: requirement for tau and APP.

Authors:  Antoneta Granic; Jaya Padmanabhan; Michelle Norden; Huntington Potter
Journal:  Mol Biol Cell       Date:  2009-12-23       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.